Dashenlin Pharmaceutical Group Co Ltd operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dashenlin Pharmaceutical Group Co Ltd with three other
companies in this sector in CHINA :
LBX PHARMACY CHAIN JSC
sales of 11.66 billion Chinese Renmimbi [US$1.67 billion]
of which 88%
was Pharmaceutical retail),
Yixintang Pharmaceutical Group Co Ltd
(10.48 billion Chinese Renmimbi [US$1.50 billion]
of which 95%
was Retail Sale), and
Yifeng Pharmacy Chain Co Ltd
(10.28 billion Chinese Renmimbi [US$1.47 billion]
of which 93%
was Medicine Retail).
Dashenlin Pharmaceutical Group Co Ltd reported sales of 11.14 billion Chinese Renmimbi (US$1.60 billion)
December of 2019.
increase of 25.8%
versus 2018, when the company's sales were 8.86 billion Chinese Renmimbi.
Sales at Dashenlin Pharmaceutical Group Co Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 145%).